宫颈癌腹主动脉旁淋巴引流区预防性放疗的研究现状  

Research status of prophylactic irradiation to para-aortic lymph nodes in cervical cancer

作　　者：刘叶红 郭旗[1] 田野[1] Liu Yehong;Guo Qi;Tian Ye(Department of Radiotherapy Oncology,The Second Affiliated Hospital of Soochow University.Institute of Radiotherapy Oncology,Soochow University,Suzhou Key Ijiboratory for Radiation Oncology,Suzhou 215004,China)

机构地区：[1]苏州大学附属第二医院,放疗科苏州大学放射肿瘤治疗学研究所,苏州市肿瘤放射治疗学重点实验室,215004

出　　处：《中华放射肿瘤学杂志》2019年第2期146-150,共5页Chinese Journal of Radiation Oncology

基　　金：江苏省医学创新团队(CXDT-37);苏州市科技发展计划(SZS201509).

摘　　要：接受盆腔同步放化疗的宫颈癌患者腹主动脉旁淋巴结复发率高约10%,严重影响宫颈癌患者的预后。有研究提出对局部晚期宫颈癌的高危患者在盆腔放化疗的基础上行腹主动脉旁淋巴引流区预防性放疗。本文分析了腹主动脉旁淋巴引流区预防性放疗的疗效、适用人群、靶区上界、预防剂量及不良反应。The recurrence rate of para-aortic lymph nodes in patients with cervical cancer un(.lergoing concurrent|)elvic chemoradiotherapy is approximately 10%,which seriously affects the prognosis of patients with cei^ical cancer.Some researchers suggest that high-risk patients with locally advanced cervical cancer undergo prophylactic irradiation to the para-aortic lymph nodes based on pelvic chemoradiotherapy.In this article,the clinical efficacy,the applicable population,the upper margin of the target volume,the preventive dose and the side effects of prophylactic irradiation to the para-aortic lymphatic nodes were analyzed.

关 键 词：宫颈恶性肿瘤 腹主动脉旁淋巴引流区放疗 预防性放疗 

分 类 号：R737.33[医药卫生—肿瘤] R730.55[医药卫生—临床医学]